Director, Pathology Drug Safety Research and Evaluation (DSRE), Head of Investigative Pathology
Initial Therapeutics, Inc.

Business Development Manager / Director, DP&C (Discovery, Preclinical & CMC) - Boston
Pharmaron Beijing Co. Ltd.
